Positron Emission Tomography (PET) Scanners Market- Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Market Overview
The global Positron Emission Tomography (PET) Scanners Market was valued at USD 1,305 million in 2024 and is projected to reach USD 1,942.81 million by 2032, growing at a compound annual growth rate (CAGR) of 5.1% during the forecast period (2024–2032).

Market growth is primarily driven by the increasing prevalence of chronic diseases, including cancer, neurological disorders, and cardiovascular conditions, which necessitate precise and early-stage diagnostic imaging. The expanding adoption of hybrid imaging systems such as PET-CT and PET-MRI is enhancing diagnostic precision while minimizing radiation exposure, thereby boosting market adoption. Technological innovations in radiopharmaceuticals, particularly the introduction of advanced tracers, are improving disease detection and facilitating targeted therapy planning. Additionally, the aging global population, more susceptible to chronic illnesses, is expected to significantly contribute to the rising demand for PET imaging. Integration of artificial intelligence (AI) into PET workflows is further optimizing image interpretation, enhancing diagnostic accuracy, and improving operational efficiency across healthcare facilities.

Market Drivers
Technological Advancements in PET Imaging
Ongoing advancements in PET technology are playing a crucial role in elevating diagnostic accuracy and clinical efficiency. Innovations such as digital PET systems and hybrid imaging modalities (PET-CT and PET-MRI) are delivering significantly improved sensitivity and spatial resolution—up to 70% higher than analogue systems—resulting in shorter scan times and enhanced patient experiences. The incorporation of AI into imaging platforms is further advancing capabilities by facilitating faster image reconstruction, reducing radiation doses, and streamlining clinical workflows. These enhancements are expanding PET’s utility in diverse clinical applications and making it increasingly accessible to healthcare providers.

Market Challenges Analysis
High Capital Investment and Limited Reimbursement
One of the primary barriers to PET scanner adoption is the substantial initial investment and operational expenditure involved. According to the National Service and Technology Review Advisory Committee, setting up a full-scale PET imaging facility can exceed USD 13 million, which poses financial challenges for small-scale hospitals and rural healthcare centers. This limits accessibility in underserved areas. Additionally, strict regulatory requirements and limited reimbursement policies further restrict PET scan utilization. The Centers for Medicare and Medicaid Services (CMS) impose reimbursement limitations—such as permitting only a single lifetime scan for Alzheimer’s diagnosis—which hinders widespread clinical adoption, despite the proven diagnostic value of PET imaging.

Market Segmentation
By Product Type:

Standalone PET Systems

PET/CT Systems

PET/MRI Systems

By Application:

Oncology

Cardiology

Neurology

Other Applications

By End User:

Hospitals

Diagnostic & Imaging Clinics

Ambulatory Surgical Centres

Other Healthcare Facilities

By Geography:

North America

U.S.

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Spain

Rest of Europe

Asia Pacific

China

Japan

India

South Korea

Southeast Asia

Rest of Asia Pacific

Latin America

Brazil

Argentina

Rest of Latin America

Middle East & Africa

GCC Countries

South Africa

Rest of Middle East and Africa

Key Player Analysis

GE Healthcare

Siemens Healthineers

Koninklijke Philips N.V.

Canon Medical Systems Corporation

Hitachi, Ltd.

Positron Corporation

United Imaging Healthcare Co., Ltd.

Shimadzu Corporation

Mediso Ltd.

Cubresa Inc.